Description
RC148 is an experimental compound being evaluated in combination with chemotherapy for first-line treatment of unresectable or metastatic colorectal cancer. Based on available clinical trial data, RC148 is designed as combination therapy alongside standard chemotherapy regimens for advanced CRC patients. The agent has progressed to Phase II/III clinical testing, indicating preliminary efficacy signals in earlier-phase studies.
Mechanism of Action
The specific molecular mechanism of action for RC148 has not been publicly disclosed in available clinical trial documentation. The compound appears to work synergistically with standard chemotherapy agents to enhance anti-tumor activity in colorectal cancer patients.
Molecular Targets
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Brand Name | Not yet branded |
| Category | Other Medications |
 Status | Experimental |
| Clinical Trials | 1 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.